Mineral and bone disorders in chronic kidney disease and end-stage renal disease patients: new insights into vitamin D receptor activation
about
Treatment with oral paricalcitol in daily clinical practice for patients with chronic kidney disease stage 3-4: a preliminary study.Clinical and Practical Use of Calcimimetics in Dialysis Patients With Secondary Hyperparathyroidism.Renocardiovascular Biomarkers: from the Perspective of Managing Chronic Kidney Disease and Cardiovascular Disease.Phosphate and FGF-23 homeostasis after kidney transplantation.Persistent hyperparathyroidism is a major risk factor for fractures in the five years after kidney transplantation.Effects of Lowering Dialysate Calcium Concentration on Mineral and Bone Disorders in Chronic Hemodialysis Patients: Conversion from 3.0 mEq/L to 2.75 mEq/L.
P2860
Mineral and bone disorders in chronic kidney disease and end-stage renal disease patients: new insights into vitamin D receptor activation
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Mineral and bone disorders in ...... vitamin D receptor activation
@en
Mineral and bone disorders in ...... vitamin D receptor activation
@nl
type
label
Mineral and bone disorders in ...... vitamin D receptor activation
@en
Mineral and bone disorders in ...... vitamin D receptor activation
@nl
prefLabel
Mineral and bone disorders in ...... vitamin D receptor activation
@en
Mineral and bone disorders in ...... vitamin D receptor activation
@nl
P2860
P356
P1476
Mineral and bone disorders in ...... vitamin D receptor activation
@en
P2093
Jordi Bover
P2860
P2888
P304
P356
10.1038/KISUP.2011.28
P577
2011-09-01T00:00:00Z